Otsuka Reaches $900M Deal For Oncology Drug Co. Astex
Japanese drugmaker Otsuka Holdings Co. Ltd. will buy California-based oncology drug developer Astex Pharmaceuticals Inc. for an estimated 90 billion yen ($900 million), according to a Wednesday report....To view the full article, register now.
Already a subscriber? Click here to view full article